| 000 | 01906 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518024931.0 | ||
| 264 | 0 | _c20200207 | |
| 008 | 202002s 0 0 eng d | ||
| 022 | _a1538-7445 | ||
| 024 | 7 |
_a10.1158/0008-5472.CAN-18-2711 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHayes, Tikvah K | |
| 245 | 0 | 0 |
_aA Functional Landscape of Resistance to MEK1/2 and CDK4/6 Inhibition in NRAS-Mutant Melanoma. _h[electronic resource] |
| 260 |
_bCancer research _c05 2019 |
||
| 300 |
_a2352-2366 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aCell Cycle Checkpoints |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase 4 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCyclin-Dependent Kinase 6 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 |
_aGTP Phosphohydrolases _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMAP Kinase Kinase 1 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMAP Kinase Kinase 2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aMembrane Proteins _xgenetics |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPhosphorylation |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aLuo, Flora | |
| 700 | 1 | _aCohen, Ofir | |
| 700 | 1 | _aGoodale, Amy B | |
| 700 | 1 | _aLee, Yenarae | |
| 700 | 1 | _aPantel, Sasha | |
| 700 | 1 | _aBagul, Mukta | |
| 700 | 1 | _aPiccioni, Federica | |
| 700 | 1 | _aRoot, David E | |
| 700 | 1 | _aGarraway, Levi A | |
| 700 | 1 | _aMeyerson, Matthew | |
| 700 | 1 | _aJohannessen, Cory M | |
| 773 | 0 |
_tCancer research _gvol. 79 _gno. 9 _gp. 2352-2366 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-18-2711 _zAvailable from publisher's website |
| 999 |
_c29426941 _d29426941 |
||